Cargando…

Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World Study

INTRODUCTION: Both mycophenolate mofetil (MMF) and intravenous cyclophosphamide (CYC) have been recommended in the induction therapy of lupus nephritis (LN) for years; nevertheless, their effectiveness and safety in a real-world setting are extremely lacking. Therefore, we decided to conduct this re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiaohui, Huang, Hong, Gao, Dai, Zhao, Juan, Ji, Lanlan, Fan, Yong, Hao, Yanjie, Zhang, Zhuoli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468445/ https://www.ncbi.nlm.nih.gov/pubmed/37418122 http://dx.doi.org/10.1007/s40744-023-00572-y

Ejemplares similares

Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008)

Mycophenolate versus Cyclophosphamide for Lupus Nephritis
por: Sahay, M., et al.
Publicado: (2018)

Comparative efficacy and safety of mycophenolate mofetil and cyclophosphamide in the induction treatment of lupus nephritis: A systematic review and meta-analysis
por: Jiang, Yue-Peng, et al.
Publicado: (2020)

Use of mycophenolate mofetil (MMF) in lupus nephritis (LN) in children
por: Indaco, R, et al.
Publicado: (2008)

Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy
por: Nawata, Takashi, et al.
Publicado: (2018)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Successful Treatment with Mycophenolate Mofetil and Tacrolimus in Juvenile Severe Lupus Nephritis
por: Kise, Tomoo, et al.
Publicado: (2015)

Efficacy of long-term maintenance therapy with mycophenolate mofetil in lupus nephritis
por: Rezaieyazdi, Zahra, et al.
Publicado: (2014)

Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial
por: Sedhain, Arun, et al.
Publicado: (2018)

Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate Mofetil
por: Nawata, Takashi, et al.
Publicado: (2017)

The development of membranous lupus nephritis during treatment with mycophenolate mofetil for proliferative renal disease
por: Dalton, Kristen, et al.
Publicado: (2010)

Combination of tacrolimus and mycophenolate mofetil in persistent proteinuria due to refractory childhood lupus nephritis
por: Almutairi, Abdulaziz, et al.
Publicado: (2018)

Mycophenolate mofetil in the treatment of Chinese patients with lupus nephritis: A PRISMA-compliant meta-analysis
por: Zhang, Haitao, et al.
Publicado: (2020)

Mycophenolate or Cyclophosphamide in Lupus Nephritis: Which One to Use in Indian Patients?
por: Rathi, Manish, et al.
Publicado: (2018)

The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
por: Hackl, A., et al.
Publicado: (2023)

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
por: Houssiau, Frédéric A, et al.
Publicado: (2010)

Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus
por: Fassbinder, Till, et al.
Publicado: (2015)

Analysis of the Clinical Effects of the Combination of Mycophenolate Mofetil with Either Tacrolimus or Cyclophosphamide
por: Zhang, Xuebing, et al.
Publicado: (2020)

Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis
por: Moore, R Andrew, et al.
Publicado: (2006)

Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy
por: Mao, Youying, et al.
Publicado: (2018)

Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis
por: Tamirou, Farah, et al.
Publicado: (2016)

Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study
por: Laskari, Katerina, et al.
Publicado: (2010)

Efficacy of High-Dose Mycophenolate Mofetil in Multitarget Therapy for Lupus Nephritis: Two Consecutive Case Reports
por: Furuto, Yoshitaka, et al.
Publicado: (2020)

Neuropsychiatric Systemic Lupus Erythematosus with Cerebral Vasculitis and Lupus Nephritis Successfully Treated with High-dose Glucocorticoids and Mycophenolate Mofetil
por: Tanaka, Saki, et al.
Publicado: (2022)

Mycophenolate Mofetil in a Lupus Patient with Pulmonary Hypertension
por: Machireddy, Kirthi, et al.
Publicado: (2018)

Cost-Utility Analysis of Mycophenolate Mofetil versus Azathioprine Based Regimens for Maintenance Therapy of Proliferative Lupus Nephritis
por: Nee, Robert, et al.
Publicado: (2015)

Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis
por: Mizaki, Tomoko, et al.
Publicado: (2023)

Real-World Experience of Safety of Mycophenolate Mofetil in 119 Japanese Patients with Systemic Lupus Erythematosus: A Retrospective Single-Center Study
por: Abe, Yoshiyuki, et al.
Publicado: (2021)

Clinical Outcomes Observed among Biopsy Proven Lupus Nephritis Patients Treated with Mycophenolate Mofetil as First-line Therapy
por: Timlin, Homa, et al.
Publicado: (2017)

Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review
por: Margiotta, Domenico Paolo Emanuele, et al.
Publicado: (2018)

Real-World Efficacy and Safety of Mycophenolate Mofetil in Active Moderate-to-Sight-Threatening Thyroid Eye Disease
por: Quah Qin Xian, Nicole, et al.
Publicado: (2021)

Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
por: Marques, R, et al.
Publicado: (2010)

Mycophenolate Mofetil Use in Severe Myocarditis Complicating Systemic Lupus
por: Allaoui, Abire, et al.
Publicado: (2022)

Ciclosporin/cyclophosphamide/mycophenolate mofetil: Bacterial, viral and fungal infections: 71 case reports
Publicado: (2019)

Mycophenolate mofetil for the treatment of Henoch-Schönlein purpura nephritis; current knowledge and new concepts
por: Nickavar, Azar, et al.
Publicado: (2017)

Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience
por: Baqir, Misbah, et al.
Publicado: (2017)

A real-world assessment of mycophenolate mofetil for remission induction in eosinophilic granulomatosis with polyangiitis
por: Philobos, Mariana, et al.
Publicado: (2021)

Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
por: Wang, Pengfei, et al.
Publicado: (2023)

Mycophenolate Mofetil (MMF) for the treatment of juvenile onset systemic lupus erythematosus
por: Falcini, FF, et al.
Publicado: (2008)

Mycophenolate Mofetil for Systemic Lupus Erythematosus: Our 20-Year Experience
por: Trevisonno, Michael, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qua5tvvkonl0v1csehaua8g9ch